Even though I have had over 20 years of growing success in using the immune modulators on patients, I never considered conducting official clinical trials.
There is of course, the moral issue of putting half of the people enrolled in the trial group, who are suffering from their disease, on a placebo medication, which I was not willing to participate in. In addition, I felt the effort would be expensive and futile in the end.
The purpose of clinical trials is to gain FDA approval for treatment of diseases. However, the FDA has never approved a natural product for treatment of disease, since its inception, and in all likelihood, never will. I sadly concluded that there was no point in even trying.
Unfortunately, in the course of our busy lives, the most obvious answers sometimes elude us.
It all became clear to me while I was on the phone with a patient who had just recovered from Lupus, and was ecstatic about his successful treatment, after other doctors told him that it was “incurable.”
He has just sent in a 100% recovery report.
However, he was frustrated that those close to him would not believe that his recovery was due to the immune modulators. While discussing the situation, he suggested that I compile his progress report along with those from other patients who were also successfully treated, and have a study run on the data from those reports.
At first, I tried to think of all the reasons why I could not do that; possibly to justify why I had not thought of doing that myself. After spending a weekend thinking about it, I could not find a single reason not to do it and every reason that I should.
The irony of it was, that even though I encourage other doctors to think outside the box and to avoid being brainwashed by the industry, here I was, succumbing to the brainwashing myself!
Who cares if the study would not involve a placebo?
Which placebo ever repeatedly healed chronic degenerative autoimmune diseases, classified as incurable?
Of course, the statistics would demonstrate therapeutic results similar to what I had been experiencing with patients.
Was I worried about being criticized by my peers?
If the studies resulted in more people being healed, then none of these baseless concerns would matter anyway.
Soon after, I called Pristine Nutraceuticals and requested copies of their progress reports, submitted from patients taking the immune modulators. I asked for two random time frame samplings, involving approximately 200 patients each.
A week later, I received the reports without any personal information identifying the patient. I called a few clinical research coordinators and began to lay the groundwork. Two weeks later the data was being extrapolated. Two months later the results were in.
- Both studies mirrored my experience with patients suffering with autoimmune conditions, showing on average an 80 to 90% therapeutic improvement in a period of 12 months.
- The data compiled from Phase 1 Safety Data, Phase 2 and Phase 3 Clinical Trials show promise in changing the direction of modern medical treatment away from the harmful drug-based methodology, which has recently been designated by Johns Hopkins University as the “Third Leading Cause of Death”. Instead, it is moving towards an effective, harmless and natural therapeutic approach.
- Phase 4 Clinical Study data is presently being compiled from patient records from numerous doctors and Natural Healing Practitioners, using DigestaCure® AUTOIMMUNE-X® on their patients. So far, the Phase 4 doctor/ patient data, also shows similar findings to those observed in the Phase 2 and Phase 3 trials.
An overview of the Phase 2 and Phase 3 Clinical Trials can be found in the articles linked below and you can read the summary in the article,Key Findings from the Phase 2 & Phase 3 Clinical Trial on DigestaCure® AUTOIMMUNE-X®.
I encourage you to go through them to find out more about the studies that demonstrate the therapeutic effects of DigestaCure® Autoimmune X®
Phase 2 Clinical Trial
PHASE 2 CLINICAL TRIAL for Safety and Effectiveness on: DigestaCure® AUTOIMMUNE-X® (PDF)
Phase 3 Clinical Trial
PHASE 3 CLINICAL TRIAL for Safety and Effectiveness on: DigestaCure® AUTOIMMUNE-X® (PDF)